PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

CEO of Concert Pharmaceuticals Speaks on how the Company is Applying its Proprietary DCE (Deuterated Chemical Energy) Platform to Modify Drug Molecules with Healthcare Global

CEO of Concert Pharmaceuticals speaks on the company's expansive pipeline of products by applying its proprietary DCE (deuterated chemical entity) Platform to modify specific properties of validated drug molecules.

CEO of Concert Pharmaceuticals Speaks on how the Company is Applying its Proprietary DCE (Deuterated Chemical Energy) Platform to Modify Drug Molecules with Healthcare Global
2011-06-30
SAN DIEGO, CA, June 30, 2011 (Press-News.org) In a report in Healthcare Digital, Roger Tung, CEO of Concert Pharmaceuticals speaks on the company's expansive pipeline of products by applying its proprietary DCE (deuterated chemical entity) Platform to modify specific properties of validated drug molecules. Concert Pharmaceuticals is using its deuterium chemistry technology to create new and different patentable drugs for the treatment of HIV, pain/spasticity, epilepsy, oncology, diabetic nephropathy, among other ailments.

To date, Concert Pharmaceuticals has more than 90 patent applications for new drug candidates tackling a broad range of therapeutic areas. In addition to a strong management team and Board of Directors, Concert Pharmaceuticals prides its success on the support of venture capitalists and other investors who have supported its research and development and pipeline advancement. The company has raised more than $110 million since its inception.

While Concert Pharmaceuticals currently conducts research and development on several programs, taking an approach that is unique in the industry. "The approach we take is unusual in the fact that we start out with compounds that have very well understood pharmacological activity and are often known to be well tolerated," says Roger Tung, CEO of Concert Pharmaceuticals. "We carry out these processes with an atom called deuterium, which is a relative of hydrogen that, in favorable cases, can change the metabolism of compounds and improve their suitability for the treatment of disease. Our two lead drug candidates treat chronic kidney disease, particularly diabetic nephropathy, and HIV infection."

Read the article here.

About Concert Pharmaceuticals:
Founded in April 2006, Concert Pharmaceuticals is a clinical stage biotechnology company dedicated to creating new medicines through a novel scientific approach utilizing the naturally-occurring element deuterium.

Concert applies its proprietary DCE Platform (deuterated chemical entity platform) to modify specific properties of validated drug molecules, yielding a rich pipeline of new chemical entities (NCEs). Concert leverages decades of pharmaceutical experience to create novel drug candidates with potential for best-in-class efficacy and safety, while greatly reducing R&D risk, time and expense.

About Healthcare Global
Healthcare Global is a pioneering digital media site for Healthcare professionals and executives responsible for all aspects of managing this environment. Healthcare Global covers solutions that enable global healthcare executives to improve the way they manage their operations. Healthcare Digital is the industry-dedicated arm of the White Digital Media Group. Founded in 2007 by entrepreneur Glen White, White Digital Media retains a diversified portfolio of websites, magazines, daily news feeds and weekly e-newsletters that leverage technology to innovatively deliver high-quality content, analytical data, and industry news.

Healthcare Global is headquartered in San Diego, California, with additional offices in Boston, Toronto, Mumbai and Norwich, England. For more information, contact 760-827-7800 or visit http://www.healthcare-digital.com.

[Attachments] See images for this press release:
CEO of Concert Pharmaceuticals Speaks on how the Company is Applying its Proprietary DCE (Deuterated Chemical Energy) Platform to Modify Drug Molecules with Healthcare Global

ELSE PRESS RELEASES FROM THIS DATE:

Peter Madeja, President and CEO of GENEX Services Speaks on How the Company's Cost-Efficient and Fully Integrated Care Management Insurance Assistance is Changing the Industry

Peter Madeja, President and CEO of GENEX Services Speaks on How the Companys Cost-Efficient and Fully Integrated Care Management Insurance Assistance is Changing the Industry
2011-06-30
In a report in Manufacturing Digital, Peter Madeja, President and CEO of GENEX Services speaks on the company's insurance services are assisting employers throughout the nation. Since its inception in 1978, GENEX Services has been providing cost-efficient and fully integrated care management insurance assistance to the occupational, non-occupational, automobile and group healthcare markets. The company's client list varies and ranges from insurance carriers, self-insured employers, and managed care organizations with more than 1,500 clients throughout the U.S., Canada ...

Paul Hertensen, Founder of B.O.V. Solutions Speaks on How the Company's Bag-on-Valve and Continuous Spray Solutions is Making for a More Sustainable Retail Market

Paul Hertensen, Founder of B.O.V. Solutions Speaks on How the Companys Bag-on-Valve and Continuous Spray Solutions is Making for a More Sustainable Retail Market
2011-06-30
In a report in Manufacturing Digital, Paul Hertensen, Founder of B.O.V. Solutions speaks on the company's roots and bag-on-valve systems and continuous spray technologies for household aerosol products. B.O.V. Solutions is a single source global supplier of bag-on-valve components and can be found in cans, actuators, over caps, among other products and items. Additionally, B.O.V. Solutions is a contract packaging company with significant quality control procedures to make for an integrated business. In conjunction with its packaging capabilities and facilities, the ...

Lundy Construction: Building for Natural Gas in Energy Digital

Lundy Construction: Building for Natural Gas in Energy Digital
2011-06-30
Energy Digital takes a look at Lundy Construction. CEO Frank Lundy III comments on the company's ability to meet the demands of a promising new market. "We're now providing various services for the natural gas industry. Particularly, we provide metal building construction to protect the industry's multimillion-dollar equipment investments. We have a crane business and provide basic construction services to the gas industry. We can handle almost any request they may have, and if we can't, we can get someone very reliable involved who can through our extensive base of ...

Kudu: The Leader in Progressing Cavity Pump Technology in Energy Digital

Kudu: The Leader in Progressing Cavity Pump Technology in Energy Digital
2011-06-30
Energy Digital takes a look at Kudu Industries Inc. "Since we first started, our business model has been to go straight to the customer, which our competitors weren't doing," explains cofounder and CEO Ray Mills. "Because we went direct, we were able to understand the customers' challenges with the technology and how it was being applied or misapplied." Close relationships with clients have motivated Kudu to implement innovations that will satisfy customer needs. "Our product information over the years has set us apart. We've had more patents ...

Charleston Couple Purchases Anago Master Franchise - Former Unit Franchisees Living the Dream of Owning Their Own Master

2011-06-30
Natives of Michigan, the Ruyts' have owned and operated several businesses in the Charleston area. Dave Ruyts served in the U.S. Navy for 10 years, and his last tour of duty brought them to Charleston. After thinking about the long, cold winters of their former state of residence, the Ruyts family decided to stay and enjoy the beautiful South Carolina weather permanently. They have lived in Charleston now, for over 25 years. The Ruyts' purchased a Janitorial Franchise from a different commercial cleaning company in the Charleston area in the mid-1990s and operated it ...

Marcel Heugen to Support PPT VISION's European Market Development Strategies

Marcel Heugen to Support PPT VISIONs European Market Development Strategies
2011-06-30
Marcel Heugen, an expert in machine vision and industrial automation engineering, will now serve as a senior consultant for PPT VISION's European headquarters here. In this role, he will support PPT VISION's European Operations, headquartered in the Netherlands, under the direction of Ivar Keulers, European sales manager for PPT VISION. Heugen held leadership roles in machine vision engineering at Simac Masic & TSS bv, SAC GmbH (Sirius Advanced Cybernetics) before launching his own business, SAC Nederland, Vision Competence Center, in 2005. In his new assignment, ...

Isurus Market Research Releases Research-Based Recommendations for Achieving Growth in Services Businesses

2011-06-30
Isurus, a leading B2B market research provider, today announced new findings for companies focused on achieving growth from their Services businesses. Isurus' research across a range of industries points to common missteps, and provides clear recommendations for avoiding or solving these issues. "One of the clear themes in our research is a lack of focus in the services portfolio. When companies build their services portfolio by reacting to isolated needs or customer requests, it leads to a range of services that aren't focused around a broader strategy for the ...

Bird and Co Announces the Launch of New Website for Park House Stables, Kingsclere

2011-06-30
Web design company Bird and Co has recently announced the launch of their newly designed website for racehorse trainer Andrew Balding of Park House Stables, Kingsclere. Visitors to the new website will gain an insight into life at the stables, the racehorse training facilities, horses in training and information about the Balding family. In particular, racehorse owners can now obtain the latest entries and race results plus news from the yard, whilst prospective owners can gain assurance that the level of care and training which their horse will receive will be first class. Bird ...

Shaker Museum and North Bennet Street School to Teach Workshops on Traditional Woodworking and Preservation Carpentry Skills

Shaker Museum and North Bennet Street School to Teach Workshops on Traditional Woodworking and Preservation Carpentry Skills
2011-06-30
For the third summer, Boston's acclaimed North Bennet Street School (www.nbss.edu) is collaborating with the Shaker Museum and Library (www.shakermuseumandlibrary.org), to offer a range of workshops in preservation and traditional woodworking at the museum's North Family at Mount Lebanon Shaker Village site. The 2011 workshops are for anyone interested in acquiring a foundation of time-honored hand skills that they can immediately put to use including individuals who wish to advance their careers in historic preservation, people interested in fine woodworking as hobby ...

A New Issue of Russian Survey is Available Now: Publication Especially for Foreign Readers

2011-06-30
What is the Russian Direct Investment Fund and who will be able to avail of its resources? What guarantees can be inferred from the "investment commandments" addressed by the Russian President to foreign investors? Is it commercially expedient to invest in the Russian industry and, if so, which branch of it is a better option? Why does Russia grant tax concessions to qualified foreign professionals and who is eligible to claim this status? These questions are answered, along with many others concerning the specific aspects of investments and doing business ...

LAST 30 PRESS RELEASES:

New perspective highlights urgent need for US physician strike regulations

An eye-opening year of extreme weather and climate

Scientists engineer substrates hostile to bacteria but friendly to cells

New tablet shows promise for the control and elimination of intestinal worms

Project to redesign clinical trials for neurologic conditions for underserved populations funded with $2.9M grant to UTHealth Houston

Depression – discovering faster which treatment will work best for which individual

Breakthrough study reveals unexpected cause of winter ozone pollution

nTIDE January 2025 Jobs Report: Encouraging signs in disability employment: A slow but positive trajectory

Generative AI: Uncovering its environmental and social costs

Lower access to air conditioning may increase need for emergency care for wildfire smoke exposure

Dangerous bacterial biofilms have a natural enemy

Food study launched examining bone health of women 60 years and older

CDC awards $1.25M to engineers retooling mine production and safety

Using AI to uncover hospital patients’ long COVID care needs

$1.9M NIH grant will allow researchers to explore how copper kills bacteria

New fossil discovery sheds light on the early evolution of animal nervous systems

A battle of rafts: How molecular dynamics in CAR T cells explain their cancer-killing behavior

Study shows how plant roots access deeper soils in search of water

Study reveals cost differences between Medicare Advantage and traditional Medicare patients in cancer drugs

‘What is that?’ UCalgary scientists explain white patch that appears near northern lights

How many children use Tik Tok against the rules? Most, study finds

Scientists find out why aphasia patients lose the ability to talk about the past and future

Tickling the nerves: Why crime content is popular

Intelligent fight: AI enhances cervical cancer detection

Breakthrough study reveals the secrets behind cordierite’s anomalous thermal expansion

Patient-reported influence of sociopolitical issues on post-Dobbs vasectomy decisions

Radon exposure and gestational diabetes

EMBARGOED UNTIL 1600 GMT, FRIDAY 10 JANUARY 2025: Northumbria space physicist honoured by Royal Astronomical Society

Medicare rules may reduce prescription steering

Red light linked to lowered risk of blood clots

[Press-News.org] CEO of Concert Pharmaceuticals Speaks on how the Company is Applying its Proprietary DCE (Deuterated Chemical Energy) Platform to Modify Drug Molecules with Healthcare Global
CEO of Concert Pharmaceuticals speaks on the company's expansive pipeline of products by applying its proprietary DCE (deuterated chemical entity) Platform to modify specific properties of validated drug molecules.